ED China guidelines

ED China guidelines

Low-intensity extracorporeal shockwave therapy In recent years, low-intensity extracorporeal shockwave therapy (LI-ESWT) is becoming the innovative therapy to treat ED 144. In the early randomized double-blind controlled study, LI-ESWT has positive effect in short-term clinical efficacy and physiological influence to those ED patients who use PED5 inhibitors145. ED1000 is approved in our country and has done a lot of long-term clinical studies abroad. Rosen 146 reported that ED1000 has a 70% effective rate to ED patients who are responsive to PDE5. Moreover, Kitrey 147 found that it has certain effect to ED patients who are non-responders to PDE5 and after treatment, 60.8% patients changed from non-responders to responders. In addition, Gruenwald 148 indicated that LI-ESWT is effective to diabetic ED patients and the effective rate is 56%.